Bayer more stringent in glyphosate settlement talks due to downturn

spike

FILE PHOTO: The logo of Bayer AG is seen in a showroom of the German drugmaker where the annual results news conference takes place in Leverkusen, Germany February 27, 2020. REUTERS/Wolfgang Rattay

FRANKFURT (Reuters) – German drugs and pesticides company Bayer said the economic downturn due to the coronavirus has prompted it to take a tougher stance in talks to settle claims its glyphosate-based weedkillers cause cancer.

The pandemic has significantly slowed the mediation process, it said in a statement on Monday.

“The company will consider a deal only if it is financially reasonable and puts in place a mechanism

Read More